249 related articles for article (PubMed ID: 34055629)
1. CRISPR/Cas9 uPAR Gene Knockout Results in Tumor Growth Inhibition, EGFR Downregulation and Induction of Stemness Markers in Melanoma and Colon Carcinoma Cell Lines.
Biagioni A; Chillà A; Del Rosso M; Fibbi G; Scavone F; Andreucci E; Peppicelli S; Bianchini F; Calorini L; Li Santi A; Ragno P; Margheri F; Laurenzana A
Front Oncol; 2021; 11():663225. PubMed ID: 34055629
[TBL] [Abstract][Full Text] [Related]
2. uPAR Knockout Results in a Deep Glycolytic and OXPHOS Reprogramming in Melanoma and Colon Carcinoma Cell Lines.
Biagioni A; Laurenzana A; Chillà A; Del Rosso M; Andreucci E; Poteti M; Bani D; Guasti D; Fibbi G; Margheri F
Cells; 2020 Jan; 9(2):. PubMed ID: 32012858
[TBL] [Abstract][Full Text] [Related]
3. Downregulation of uPAR promotes urokinase translocation into the nucleus and epithelial to mesenchymal transition in neuroblastoma.
Semina EV; Rubina KA; Shmakova AA; Rysenkova KD; Klimovich PS; Aleksanrushkina NA; Sysoeva VY; Karagyaur MN; Tkachuk VA
J Cell Physiol; 2020 Sep; 235(9):6268-6286. PubMed ID: 31990070
[TBL] [Abstract][Full Text] [Related]
4. uPAR-expressing melanoma exosomes promote angiogenesis by VE-Cadherin, EGFR and uPAR overexpression and rise of ERK1,2 signaling in endothelial cells.
Biagioni A; Laurenzana A; Menicacci B; Peppicelli S; Andreucci E; Bianchini F; Guasti D; Paoli P; Serratì S; Mocali A; Calorini L; Del Rosso M; Fibbi G; Chillà A; Margheri F
Cell Mol Life Sci; 2021 Mar; 78(6):3057-3072. PubMed ID: 33237352
[TBL] [Abstract][Full Text] [Related]
5. Targeting uPAR by CRISPR/Cas9 System Attenuates Cancer Malignancy and Multidrug Resistance.
Wang K; Xing ZH; Jiang QW; Yang Y; Huang JR; Yuan ML; Wei MN; Li Y; Wang ST; Liu K; Shi Z
Front Oncol; 2019; 9():80. PubMed ID: 30873379
[TBL] [Abstract][Full Text] [Related]
6. Urokinase Receptor uPAR Downregulation in Neuroblastoma Leads to Dormancy, Chemoresistance and Metastasis.
Shmakova AA; Klimovich PS; Rysenkova KD; Popov VS; Gorbunova AS; Karpukhina AA; Karagyaur MN; Rubina KA; Tkachuk VA; Semina EV
Cancers (Basel); 2022 Feb; 14(4):. PubMed ID: 35205745
[TBL] [Abstract][Full Text] [Related]
7. Urokinase-Type Plasminogen Activator Receptor (uPAR) Cooperates with Mutated
Peng L; Li Y; Yao S; Gaedcke J; Baart VM; Sier CFM; Neesse A; Ellenrieder V; Bohnenberger H; Fuchs F; Kitz J; Ströbel P; Küffer S
Cancers (Basel); 2023 Mar; 15(5):. PubMed ID: 36900379
[TBL] [Abstract][Full Text] [Related]
8. Overexpression of the urokinase receptor mRNA splice variant uPAR-del4/5 affects tumor-associated processes of breast cancer cells in vitro and in vivo.
Sato S; Kopitz C; Grismayer B; Beaufort N; Reuning U; Schmitt M; Luther T; Kotzsch M; Krüger A; Magdolen V
Breast Cancer Res Treat; 2011 Jun; 127(3):649-57. PubMed ID: 20635136
[TBL] [Abstract][Full Text] [Related]
9. Cellular glycosylphosphatidylinositol-specific phospholipase D regulates urokinase receptor shedding and cell surface expression.
Wilhelm OG; Wilhelm S; Escott GM; Lutz V; Magdolen V; Schmitt M; Rifkin DB; Wilson EL; Graeff H; Brunner G
J Cell Physiol; 1999 Aug; 180(2):225-35. PubMed ID: 10395292
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of urokinase-type plasminogen activator receptor induces apoptosis in melanoma cells by activation of p53.
Besch R; Berking C; Kammerbauer C; Degitz K
Cell Death Differ; 2007 Apr; 14(4):818-29. PubMed ID: 17110957
[TBL] [Abstract][Full Text] [Related]
11. The Urokinase Receptor Induces a Mesenchymal Gene Expression Signature in Glioblastoma Cells and Promotes Tumor Cell Survival in Neurospheres.
Gilder AS; Natali L; Van Dyk DM; Zalfa C; Banki MA; Pizzo DP; Wang H; Klemke RL; Mantuano E; Gonias SL
Sci Rep; 2018 Feb; 8(1):2982. PubMed ID: 29445239
[TBL] [Abstract][Full Text] [Related]
12. DU145 human prostate carcinoma invasiveness is modulated by urokinase receptor (uPAR) downstream of epidermal growth factor receptor (EGFR) signaling.
Mamoune A; Kassis J; Kharait S; Kloeker S; Manos E; Jones DA; Wells A
Exp Cell Res; 2004 Sep; 299(1):91-100. PubMed ID: 15302576
[TBL] [Abstract][Full Text] [Related]
13. Regulation of urokinase receptor mRNA stability by hnRNP C in lung epithelial cells.
Shetty S
Mol Cell Biochem; 2005 Apr; 272(1-2):107-18. PubMed ID: 16010978
[TBL] [Abstract][Full Text] [Related]
14. RNA interference-directed knockdown of urokinase plasminogen activator and urokinase plasminogen activator receptor inhibits prostate cancer cell invasion, survival, and tumorigenicity in vivo.
Pulukuri SM; Gondi CS; Lakka SS; Jutla A; Estes N; Gujrati M; Rao JS
J Biol Chem; 2005 Oct; 280(43):36529-40. PubMed ID: 16127174
[TBL] [Abstract][Full Text] [Related]
15. Expression of urokinase-type plasminogen activator/urokinase-type plasminogen activator receptor and maspin in oral squamous cell carcinoma: Association with mode of invasion and clinicopathological factors.
Yoshizawa K; Nozaki S; Kitahara H; Kato K; Noguchi N; Kawashiri S; Yamamoto E
Oncol Rep; 2011 Dec; 26(6):1555-60. PubMed ID: 21833477
[TBL] [Abstract][Full Text] [Related]
16. CRISPR/Cas9 nickase mediated targeting of urokinase receptor gene inhibits neuroblastoma cell proliferation.
Rysenkova KD; Semina EV; Karagyaur MN; Shmakova AA; Dyikanov DT; Vasiluev PA; Rubtsov YP; Rubina KA; Tkachuk VA
Oncotarget; 2018 Jun; 9(50):29414-29430. PubMed ID: 30034627
[TBL] [Abstract][Full Text] [Related]
17. Coordinated expression of the vitronectin receptor and the urokinase-type plasminogen activator receptor in metastatic melanoma cells.
Nip J; Rabbani SA; Shibata HR; Brodt P
J Clin Invest; 1995 May; 95(5):2096-103. PubMed ID: 7537755
[TBL] [Abstract][Full Text] [Related]
18. Urokinase-type plasminogen activator receptor (uPAR), tissue factor (TF) and epidermal growth factor receptor (EGFR): tumor expression patterns and prognostic value in oral cancer.
Christensen A; Kiss K; Lelkaitis G; Juhl K; Persson M; Charabi BW; Mortensen J; Forman JL; Sørensen AL; Jensen DH; Kjaer A; von Buchwald C
BMC Cancer; 2017 Aug; 17(1):572. PubMed ID: 28841839
[TBL] [Abstract][Full Text] [Related]
19. Posttranscriptional regulation of urokinase receptor gene expression in human lung carcinoma and mesothelioma cells in vitro.
Shetty S; Idell S
Mol Cell Biochem; 1999 Sep; 199(1-2):189-200. PubMed ID: 10544967
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of uPAR-TGFβ crosstalk blocks MSC-dependent EMT in melanoma cells.
Laurenzana A; Biagioni A; Bianchini F; Peppicelli S; Chillà A; Margheri F; Luciani C; Pimpinelli N; Del Rosso M; Calorini L; Fibbi G
J Mol Med (Berl); 2015 Jul; 93(7):783-94. PubMed ID: 25694039
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
